#CTAD26: Priavoid’s amyloid-detangling pill PRI-002 fails Phase 2 study in Alzheimer’s
BOSTON — For nearly a decade, the German biotech startup Priavoid has been working on a pill to break up small clumps of amyloid proteins that accumulate in the brains of people with Alzheimer’s disease. Now ...
comments(0)
5-min edit window · permanent after that